Discover 427 paid clinical trials in Lexington, Kentucky. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 427
MOntelukast as a Potential CHondroprotective Treatment Following Anterior Cruciate Ligament Reconstruction (MOCHA Trial)
Time-restricted Eating for Patients With Type 2 Diabetes
for
Type 2 Diabetes
Location: Lexington KY
Sponsor: Justin (Matt) Thomas
Sex: All
Age: 18+
Code: NCT07318207
Recruiting
A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants
for
Gout
Location: Lexington KY, Dayton OH, Shelby NC, Charlotte NC,
Sponsor: Crystalys Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT07535034
Phase 2, Recruiting
Evaluation of SUMMIT BRUSH in Treatment of Blepharitis
for
Blepharitis
Location: Lexington KY, Mishawaka IN, Boulder CO
Sponsor: University of Notre Dame
Sex: All
Age: 18+
Code: NCT04603222
Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Lexington KY, Corbin KY, Indianapolis IN, Danville IL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06058377
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
for
Fallopian Tube Endometrioid Adenocarcinoma,
Location: Lexington KY, Mount Sterling KY, Bardstown KY,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT06580314
Phase 3, Recruiting
Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain
Location: Lexington KY, Jasper GA, Bermuda Run NC, Pittsburgh PA,
Sponsor: Boston Scientific Corporation
Sex: All
Age: 18+
Code: NCT06827262
Recruiting
Healthy Recovery After Trauma Study
for
Stress Disorders, Post-Traumatic, Shame, Guilt,
Location: Lexington KY
Sponsor: Christal L Badour
Sex: All
Age: 18+
Code: NCT04585685
Recruiting
Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
for
Hypertension, Uncontrolled Hypertension
Location: Lexington KY, Cincinnati OH, Tinley Park IL,
Sponsor: Vanda Pharmaceuticals
Sex: All
Age: 18 - 65
Code: NCT07090161
Phase 2, Recruiting
BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes
for
Diabetes Mellitus, Type 2
Location: Lexington KY, Beachwood OH, Wilmington DE, Boston MA,
Sponsor: Brigham and Women's Hospital
Sex: All
Age: 30+
Code: NCT05161429
Recruiting
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
for
Cardiotoxicity, HER2/Neu Positive,
Location: Lexington KY, Cincinnati OH, West Chester OH,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT03418961
Phase 3, Recruiting
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
for
Breast Carcinoma, Colorectal Carcinoma,
Location: Lexington KY, Mount Sterling KY, Bardstown KY,
Sponsor: Wake Forest University Health Sciences
Sex: All
Age: 18+
Code: NCT06418204
Recruiting
Home OCT Fluid Visualization Agreement Study
for
Neovascular Age-related Macular Degeneration
Location: Lexington KY, Marietta GA, Chesterfield MO, Richmond VA,
Sponsor: Notal Vision Inc.
Sex: All
Age: 55+
Code: NCT04907409
Recruiting
Oral Nutrition Impact on Tear Film
for
Dry Eye Syndrome
Location: Lexington KY, Oak Lawn IL, Creve Coeur MO, Conifer CO
Sponsor: Eye and Vision Technologies and Research Institute
Sex: All
Age: 18 - 70+
Code: NCT01561040
Recruiting
New
Comparing the Extent to Which Maridebart Cafraglutide is Made Available in the Body of Participants Living With Overweight or Obesity After Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA)
for
Obesity, Overweight
Location: Lexington KY, Knoxville TN, Madison WI,
Sponsor: Amgen
Sex: All
Age: 18 - 70
Code: NCT07908316
Phase 1, Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)